About: http://data.cimple.eu/news-article/6e188dc48afb6b0908f1d4e48379ab6a2562e265ac736b5ac40730b8

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/6e188dc48afb6b0908f1d4e48379ab6a2562e265ac736b5ac40730b8 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Germany on Monday opened access to Johnson & Johnson's coronavirus vaccines to all adults, lifting a priority system determining who gets the jabs first. With the majority of people over 60 expected to be already vaccinated by June, Health Minister Jens Spahn said authorities decided not to restrict the jabs to older people over very rare thrombosis risks. Rather, younger people can choose to take the vaccine, which only requires one shot, after consultation with their doctors, he said. Spahn noted that some 10 million doses of Johnson & Johnson vaccines would be delivered over June and July -- when older people who want the jabs would already have been vaccinated. "So we are lifting prioritisation for Johnson & Johnson, like we have done for AstraZeneca... so that everyone can have the possibility of getting vaccinated after clarifications with their doctors and based on their individual decisions," said Spahn. The move would allow Germany "to work on this vaccination campaign with greater speed, in a pragmatic manner". Germany had initially recommended AstraZeneca vaccines only for older people following concerns over several blood clotting cases among younger recipients of the vaccine. But it has since opened the jabs up to all adults who want them after consultations with doctors. The European Medicines Agency has said that blood clots should be listed as a rare side effect of both the Johnson & Johnson and AstraZeneca jabs but that the benefits continue to outweigh risks. Both vaccines use the same adenovirus vector technology, unlike jabs made by BioNTech/Pfizer or Moderna, which are messenger RNA vaccines. hmn/dlc/wdb
schema:headline	Germany lifts priority limits to offer J&J jabs to all
schema:mentions	Adenoviridae Coagulation Thrombosis European Medicines Agency Jens Spahn Johnson & Johnson AstraZeneca Germany Messenger RNA Pfizer Vaccine Coronavirus Venous thrombosis Clarifications (The Wire) Euclidean vector The Move
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-10 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	81 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software